Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India : a prudent approach
| Errataetall: |
CommentOn: Lancet Infect Dis. 2020 Oct;20(10):1118-1119. - PMID 32311324 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 20(2020), 10 vom: 18. Okt., Seite 1119-1120 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tilangi, Praveen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.10.2020 Date Revised 07.12.2022 published: Print-Electronic CommentOn: Lancet Infect Dis. 2020 Oct;20(10):1118-1119. - PMID 32311324 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(20)30430-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310322227 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310322227 | ||
| 003 | DE-627 | ||
| 005 | 20231225135838.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(20)30430-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310322227 | ||
| 035 | |a (NLM)32450054 | ||
| 035 | |a (PII)S1473-3099(20)30430-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tilangi, Praveen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India |b a prudent approach |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.10.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Lancet Infect Dis. 2020 Oct;20(10):1118-1119. - PMID 32311324 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Desai, Devashish |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Adil |e verfasserin |4 aut | |
| 700 | 1 | |a Soneja, Manish |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 20(2020), 10 vom: 18. Okt., Seite 1119-1120 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2020 |g number:10 |g day:18 |g month:10 |g pages:1119-1120 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(20)30430-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2020 |e 10 |b 18 |c 10 |h 1119-1120 | ||